Polyneuron Pharmaceuticals AG Company

Polyneuron is pioneering a novel therapeutic approach for the effective and safe treatment of antibody-mediated autoimmune diseases where a pathological role of autoantibodies is well established. Polyneuron’s platform focus is on devastating autoimmune diseases with an unmet medical need.

Founded Date: 2014
Headquarters: Basel
Industry: PharmTech